Sepsis Management in Patients with Reduced‑Ejection‑Fraction Heart Failure

Initial Resuscitation and Early Antimicrobial Therapy

• Obtain blood cultures before starting antibiotics and administer broad‑spectrum antimicrobials within the first hour of septic shock recognition – a core element of the Critical Care Medicine guideline for sepsis care. 4
• Apply the standard 30 mL/kg crystalloid bolus within the first 3 hours, even in patients with chronic systolic heart failure (EF < 40%) – the Intensive Care Medicine guideline emphasizes that withholding fluids in this population is not supported by evidence. 1

Fluid Administration Strategy

• Continue a fluid‑challenge until hemodynamic parameters (e.g., MAP, cardiac output) improve; stop when no further benefit is observed – recommended by the Intensive Care Medicine guideline as essential to avoid delayed resuscitation‑related mortality. 2
• Use dynamic variables (pulse‑pressure variation, stroke‑volume variation) or readily available static signs (arterial pressure, heart rate, mental status, urine output) to guide ongoing fluid delivery – endorsed by the Intensive Care Medicine guideline for individualized fluid titration. 1
• Consider albumin supplementation when large volumes of crystalloids are required to maintain target MAP – the Critical Care Medicine guideline suggests albumin as an adjunct in high‑volume resuscitation. 5
• Avoid hydroxyethyl starch solutions because they increase the risk of acute kidney injury and mortality – a strong recommendation of the Intensive Care Medicine guideline. 2

Vasopressor and Inotropic Support

• Start norepinephrine as the first‑line vasopressor to achieve a MAP ≥ 65 mmHg after adequate fluid resuscitation – the Intensive Care Medicine guideline identifies norepinephrine as the vasopressor with the most favorable cardiac safety profile in heart‑failure patients. 1
• Add vasopressin (0.03 U/min) to norepinephrine when additional MAP support is needed or to allow norepinephrine dose reduction – recommended by the Intensive Care Medicine guideline. 2
• Introduce epinephrine if further pressor support is required despite norepinephrine ± vasopressin – supported by the Intensive Care Medicine guideline. 1
• Reserve dopamine for highly selected cases (e.g., bradycardic patients at low risk of tachyarrhythmia); otherwise, avoid it because it is associated with more cardiac adverse events in heart‑failure patients – a cautionary statement from the Intensive Care Medicine guideline. 2
• Administer dobutamine (up to 20 µg/kg/min) when myocardial dysfunction with low cardiac output persists despite adequate volume status and MAP, indicating ongoing hypoperfusion – the Critical Care Medicine guideline advises dobutamine for low‑output septic shock in the setting of reduced EF. 4

Hemodynamic Monitoring

• Place an arterial catheter promptly in any patient requiring vasopressor therapy to allow accurate MAP monitoring – a procedural recommendation of the Intensive Care Medicine guideline. 2

Critical Pitfalls to Avoid

• Do not use low‑dose dopamine for renal protection; evidence shows it is ineffective and contraindicated – reinforced by the Intensive Care Medicine guideline. 1

All recommendations above are derived from peer‑reviewed guideline statements (Intensive Care Medicine and Critical Care Medicine) and reflect the strongest available evidence for managing sepsis in patients with reduced‑ejection‑fraction heart failure.